Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Haemonetics Corporation (HAE)

  • Business News
  • Jan. 09, 2026, 11:15 UTC
  • 0
  • 1 comments

Haemonetics Acquires Vivasure Medical Limited

Market reaction Comment Full text

Linde PLC (LIN)

  • Business News
  • Jan. 09, 2026, 11:01 UTC
  • 0
  • 1 comments

Linde Announces Fourth Quarter 2025 Earnings and Conference Call Schedule

Market reaction Comment Full text

Kezar Life Sciences Inc (KZR)

  • Business News
  • Jan. 09, 2026, 11:01 UTC
  • 2
  • 1 comments

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis

Market reaction Comment Full text

RadNet Inc (RDNT)

  • Business News
  • Jan. 09, 2026, 11:00 UTC
  • 2
  • 1 comments

RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

Market reaction Comment Full text

Insulet Corporation (PODD)

  • Business News
  • Jan. 09, 2026, 11:00 UTC
  • 3
  • 1 comments

Insulet - Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Market reaction Comment Full text

Insulet Corporation (PODD)

  • Business News
  • Jan. 09, 2026, 11:00 UTC
  • 2
  • 1 comments

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Market reaction Comment Full text

Aoxin Q & M Dental Grp Limited (1D4)

  • Business News
  • Jan. 09, 2026, 10:12 UTC
  • 2
  • 1 comments

Q & M Dental Group (Singapore) Limited - Announcement

Market reaction Comment Full text

Zealand Pharma A/S (company was delisted NASDAQ) (ZEAL)

  • Business News
  • Jan. 09, 2026, 07:00 UTC
  • 6
  • 1 comments

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy

Market reaction Comment Full text

Fresenius Medical Care AG (FMCQF)

  • Business News
  • Jan. 09, 2026, 06:57 UTC
  • 5
  • 1 comments

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

Market reaction Comment Full text

Monte Rosa Therapeutics (GLUE)

  • Business News
  • Jan. 09, 2026, 03:49 UTC
  • 8
  • 1 comments

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering

Market reaction Comment Full text
  • Previous
  • 115
  • 116
  • 117
  • 118
  • 119
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124505)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin